Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form, in dosage forms and in the presence of its oxidative degradates

被引:25
作者
Amin, AS [1 ]
Ahmed, IS [1 ]
Dessouki, HA [1 ]
Gouda, EA [1 ]
机构
[1] Benha Univ, Fac Sci, Dept Chem, Banha, Egypt
关键词
spectrophotometry; oxidation reaction; ranitidine HCl; N-bromosuccinimide; cerium(IV) sulfate; dosage forms;
D O I
10.1016/S1386-1425(02)00226-3
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
Three simple, accurate and sensitive colorimetric methods (A, B and C) for the determination of ranitidine HCl (RHCl) in bulk sample, in dosage forms and in the presence of its oxidative degradates are described. The first method A is based on the oxidation of the drug by N-bromosuccinimide (NBS) and determination of the unreacted NBS by measurement of the decrease in absorbance of amaranth dye (AM) at a suitable lambda(max) = 520 nm. The methods B and C involve the addition of excess Ce4+ and determination of the unreacted oxidant by decrease the red color of chromotrope 2R (C2R) at a suitable lambda(max) = 528 nm for method B or decrease the orange pink color of rhodamine 6G (Rh6G) at a suitable lambda(max) = 526 nm for method C. Regression analysis of Beer-Lambert plots showed good correlation in the concentration ranges 0.2-3.6, 0.1-2.8 and 0.1-2.6 mug ml(-1) for methods A, B and C, respectively. The apparent molar absorptivity. Sandell sensitivity, detection and quantitation limits were calculated. For more accurate results, Ringbom optimum concentration ranges were 0.3-3.4, 0.2-2.6 and 0.2-2.4 mug ml(-1) for methods A, B and C, respectively. Analyzing pure and dosage forms containing RHCl tested the validity of the proposed methods. The relative standard deviations were less than or equal to1.38 with recoveries 98.9-101.0%. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:695 / 703
页数:9
相关论文
共 33 条
  • [1] DETERMINATION OF RANITIDINE IN A BIOLOGICAL-MATERIAL BY USING DIFFERENTIAL PULSE ADSORPTIVE STRIPPING VOLTAMMETRY
    ALTINOZ, S
    OZER, D
    TEMIZER, A
    BAYRAKTAR, Y
    [J]. ANALYTICAL LETTERS, 1992, 25 (01) : 111 - 118
  • [2] [Anonymous], 1978, SPECTROCHIM ACTA, VB33, P242
  • [3] [Anonymous], ANAL LETT
  • [4] ATKOSAR Z, 1989, ACTA PHARM TURC, V31, P139
  • [5] Spectrophotometric determination of certain cephalosporins through oxidation with cerium(IV) and 1-chlorobenzotriazole
    Ayad, MM
    Shalaby, AA
    Abdellatef, HE
    Elsaid, HM
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 20 (03) : 557 - 564
  • [6] Stability indicating spectrodensitometric determination of ranitidine hydrochloride using linear and non-linear regression
    El-Bayoumi, AEA
    El-Shanawany, A
    El-Sadek, ME
    El-Sattar, AA
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (04) : 867 - 873
  • [7] Emmanuel J, 1989, INDIAN DRUGS, V26, P249
  • [8] Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography
    Farthing, D
    Brouwer, KLR
    Fakhry, I
    Sica, D
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1997, 688 (02): : 350 - 353
  • [9] Determination of ranitidine in pharmaceutical preparations using manual and flow injection potentiometry and spectrophotometry
    Hassan, SSM
    Mahmoud, WH
    Othman, AHM
    [J]. ANALYTICA CHIMICA ACTA, 1996, 332 (01) : 39 - 48
  • [10] Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products
    Ho, C
    Huang, HM
    Hsu, SY
    Shaw, CY
    Chang, BL
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (03) : 379 - 385